Continuous administration of mirabegron has advantages in inhibition of central sensitization compared with short-term treatment cessation in a mouse model of overactive bladder.

Saved in:
Bibliographic Details
Title: Continuous administration of mirabegron has advantages in inhibition of central sensitization compared with short-term treatment cessation in a mouse model of overactive bladder.
Authors: Kwon J; Department of Urology, Daegu Fatima Hospital, Daegu, South Korea.; Research Institute, Daegu Fatima Hospital, Daegu, South Korea., Lee EJ; Research Institute, Daegu Fatima Hospital, Daegu, South Korea., Park HR; Research Institute, Daegu Fatima Hospital, Daegu, South Korea., Cho HJ; Research Institute, Daegu Fatima Hospital, Daegu, South Korea., Jang JA; Research Institute, Daegu Fatima Hospital, Daegu, South Korea., Yang H; Department of Anesthesiology, Daegu Fatima Hospital, Daegu, South Korea., An J; Department of Anesthesiology, Daegu Fatima Hospital, Daegu, South Korea., Park D; Department of Physical Medicine and Rehabilitation, University of Ulsan College of Medicine, Ulsan, South Korea., Kim YJ; Department of Urology, Daegu Fatima Hospital, Daegu, South Korea., Hur KJ; Department of Urology, Daegu Fatima Hospital, Daegu, South Korea., Kim JS; Department of Urology, Daegu Fatima Hospital, Daegu, South Korea., Yoshimura N; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Source: Neurourology and urodynamics [Neurourol Urodyn] 2022 Aug; Vol. 41 (6), pp. 1355-1363. Date of Electronic Publication: 2022 May 12.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6777 (Electronic) Linking ISSN: 07332467 NLM ISO Abbreviation: Neurourol Urodyn Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1520-6777
DOI:10.1002/nau.24956